AusCann Group Holdings Ltd (ASX:AC8) Share Price, News, Chart & Financials

AusCann Group Holdings Ltd

Level 5, 35 Havelock Street, WEST PERTH, WA, AUSTRALIA, 6005

+61 8 6305 0705

http://www.auscann.com.au/

Sector: Healthcare

Description

AusCann Group Holdings Ltd (ASX: AC8) is engaged in manufacturing and offering clinically validated cannabinoid medicines and aims to assist Australian patients in every regard. It has operations that run through different phases like cultivation and production, manufacture and distribution of products. The group was earlier known as TW Holdings Limited, and has been into cannabis cultivation for quite some time. They started with medications for neuropathic and chronic pain and have been targeting the opportunity in Australia primarily ($9 billion).

Peers

NVAX

Novavax Inc

ANP

Antisense Therapeutics Ltd.

PTX

Prescient Therapeutics Limited

MRNA

Moderna Inc

NOX

Noxopharm Limited

IMU

Imugene Limited

SKN

Skin Elements Ltd

PFE

Pfizer Inc

CHM

Chimeric Therapeutics Limited

RAD

Radiopharm Theranostics Limited

BPH

BPH Energy Limited

CYP

Cynata Therapeutics Limited

Top Gainer
Top Loser

Code	Price	Chg	%Chg

View All

Code	Price	Chg	%Chg

View All

Close

Companies View All

Articles View All

Definitions View All

Live News View All

AusCann Group Holdings Ltd

AusCann Group Holdings Ltd

Description

Peers

NVAX

ANP

PTX

MRNA

NOX

IMU

SKN

PFE

CHM

RAD

BPH

CYP

Related Articles